I'm not a patent lawyer but cannot see how "discovery" of Zantrene as a potent FTO inhibitor for oncology is patentable when someone else holds the patent for Zantrene. Particularly when the drug is in clinic for oncology. That would seem to undermine patent rights.
Perhaps this may actually be a stumbling block for CoHinvolving attorneys and increasing the canine affection!
RAC - Charts & Price Action, page-9416
-
- There are more pages in this discussion • 12,398 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.54 |
Change
-0.015(0.97%) |
Mkt cap ! $261.5M | |||
| Open | High | Low | Value | Volume |
| $1.55 | $1.55 | $1.50 | $111.4K | 73.35K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $1.53 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.56 | 1400 | 1 |
View Market Depth
| Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
| RAC (ASX) Chart |